Results 21 to 30 of about 5,443,463 (218)

INVASIVE PNEUMOCOCCAL DISEASES IN CHILDREN AGED 1-59 MONTHS IN SICILY, ITALY: IMPORTANCE OF ACTIVE FAMILY PAEDIATRICIAN SURVEILLANCE AND VACCINATION COVERAGE. [PDF]

Euromediterranean Biomedical Journal, 2014
Purpose: Aim of this study was to analyze pediatric invasive pneumococcal disease rates several years after the implementation of infant pneumococcal vaccination. Methods: The study was carried out in Sicily and involved about 30,000 children, aged 1-
Emanuele Amodio
doaj   +1 more source

Population-based analysis of invasive nontypeable pneumococci reveals that most have defective capsule synthesis genes. [PDF]

PLoS ONE, 2014
Since nasopharyngeal carriage of pneumococcus precedes invasive pneumococcal disease, characteristics of carriage isolates could be incorrectly assumed to reflect those of invasive isolates.
In Ho Park, K Aaron Geno, Logan K Sherwood, Moon H Nahm, Bernard Beall   +4 more
doaj   +1 more source

Intrafamilial Transmission of Pneumococcal Acute Spontaneous Peritonitis

Infectious Disease Reports, 2023
Streptococcus pneumonia (S. pneumoniae, Pneumococcus) is a major cause of childhood morbidity and mortality worldwide. The most common presentations of invasive pneumococcal disease (IPD) in children include bacteremic pneumonia, meningitis, and ...
Ioanna Papadatou, Angeliki Moudaki, Anastasia Mentessidou, Dimitrios Tsakogiannis, Elissavet Georgiadou, Vana Spoulou   +5 more
doaj   +1 more source

Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling. [PDF]

PLoS ONE, 2014
This work is the first attempt to quantify the overall effects of a 13-valent pneumococcal conjugate vaccine (PCV13) vaccination programme in the Dutch population taking into account all the direct and indirect effects of the vaccine on invasive ...
Elisabetta De Cao, Alessia Melegaro, Rogier Klok, Maarten Postma   +3 more
doaj   +1 more source

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

The Lancet Global Health, 2021
Summary: Background: The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine ...
Naor Bar-Zeev, PhD, Todd D Swarthout, MSc, Dean B Everett, ProfPhD, Maaike Alaerts, PhD, Jacquline Msefula, BSc, Comfort Brown, Dipl, Sithembile Bilima, BSc, Jane Mallewa, MD, Carina King, PhD, Anne von Gottberg, ProfPhD, Jennifer R Verani, MD, Cynthia G Whitney, MD, Charles Mwansambo, FRCPCH, Stephen B Gordon, ProfPhD, Nigel A Cunliffe, ProfPhD, Neil French, ProfPhD, Robert S Heyderman, ProfPhD   +16 more
doaj   +1 more source

The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004 [PDF]

, 2008
Background For winter 2003/2004 in Scotland, it was recommended that all those aged 65 and over be eligible to receive 23-valent polysaccharide pneumococcal vaccine (23vPPV), which has been shown to be effective in reducing the risk of invasive ...
Macfarlane, Tatania V., Weir, Amanda, Robertson, Chris, Clarke, Stuart C., Simpson, Colin R., Mooney, John D., Ritchie, Lewis D., Ahmed, Syed, McMenamin, Jim   +8 more
core   +5 more sources

Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis

Scientific Reports, 2021
Risk factors associated with mortality in invasive pneumococcal disease remain unclear. The present work is a meta-analysis of studies that enrolled only patients with invasive pneumococcal disease and reported on mortality.
Hao Chen, Hiromi Matsumoto, Nobuyuki Horita, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko   +5 more
doaj   +1 more source

Integrated genomic analysis of antibiotic resistance and virulence determinants in invasive strains of Streptococcus pneumoniae

Frontiers in Cellular and Infection Microbiology, 2023
IntroductionStreptococcus pneumoniae is an important human pathogen that may cause severe invasive pneumococcal diseases (IPDs) in young children and the elderly.
Lin Liu, Yanfei Wang, Yanfei Wang, Yanfei Wang, Lihong Ge, Dongping Hu, Xi Xiang, Ying Fu, Ying Fu, Jun Lu, Xi Li, Yunsong Yu, Yunsong Yu, Yunsong Yu, Yuexing Tu, Yuexing Tu, Xueqing Wu, Xueqing Wu, Xueqing Wu   +18 more
doaj   +1 more source

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.

PLoS ONE, 2022
Pneumococcal conjugate vaccines reduce the burden of invasive pneumococcal disease, but the sustained effect of these vaccines can be diminished by an increase in disease caused by non-vaccine serotypes.
Sweta M Patel, Yazdani B Shaik-Dasthagirisaheb, Morgan Congdon, Rebecca R Young, Mohamed Z Patel, Tiny Mazhani, Sefelani Boiditswe, Tirayaone Leburu, Kwana Lechiile, Tonya Arscott-Mills, Andrew P Steenhoff, Kristen A Feemster, Samir S Shah, Coleen K Cunningham, Stephen I Pelton, Matthew S Kelly   +15 more
doaj   +3 more sources

A pediatric case series of invasive pneumococcal disease caused by S.Pneumonia serotype-19A despite full dose vaccination

Human Vaccines & Immunotherapeutics, 2023
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia and bacterial meningitis in children. Although pneumococcal conjugate vaccines (PCVs) are commonly available, invasive pneumococcal disease (IPD) still remains a life ...
Burcu Ceylan Cura Yayla, Tugba Bedir Demirdag, Emine Akkuzu, Nursel Kara, Hasan Tezer, Anıl Tapisiz   +5 more
doaj   +1 more source